For example, TIMER 2.0 and GEPIA were utilized to evaluate the expression profile of IL-19 in several types of cancers and the results revealed that IL-19 is highly upregulated in several cancers including breast cancer. This evidence concerns the gene IL19 and breast carcinoma.